IN8bio, Inc.

IN8bio, Inc.verified

INAB

Price:

$0.8699

Market Cap:

$38.38M

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incy...[Read more]

Industry

Biotechnology

IPO Date

2021-07-30

Stock Exchange

NASDAQ

Ticker

INAB

The Enterprise Value as of July 2024 (TTM) for IN8bio, Inc. (INAB) is 31.08M

According to IN8bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 31.08M. This represents a change of -6.68% compared to the average of 33.31M of the last 4 quarters.

IN8bio, Inc. (INAB) Historical Enterprise Value (quarterly & annually)

How has INAB Enterprise Value performed in the past?

The mean historical Enterprise Value of IN8bio, Inc. over the last ten years is 89.03M. The current 31.08M Enterprise Value has changed 3.39% with respect to the historical average. Over the past ten years (40 quarters), INAB's Enterprise Value was at its highest in in the June 2021 quarter at 177.50M. The Enterprise Value was at its lowest in in the December 2019 quarter at -610000.00.

Quarterly (TTM)
Annual

Average

89.03M

Median

52.29M

Minimum

24.82M

Maximum

192.94M

IN8bio, Inc. (INAB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IN8bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 240.05%

Maximum Annual Enterprise Value = 192.94M

Minimum Annual Increase = -72.78%

Minimum Annual Enterprise Value = 24.82M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202324.82M-31.29%
202236.13M-24.48%
202147.84M-72.78%
2020175.73M-8.92%
2019192.94M240.05%

IN8bio, Inc. (INAB) Average Enterprise Value

How has INAB Enterprise Value performed in the past?

The current Enterprise Value of IN8bio, Inc. (INAB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

36.26M

5-year avg

95.49M

10-year avg

89.03M

IN8bio, Inc. (INAB) Enterprise Value vs. Peers

How is INAB’s Enterprise Value compared to its peers?

IN8bio, Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (30.14M), greater than Cue Biopharma, Inc. (13.90M), less than Lantern Pharma Inc. (33.16M), less than Gracell Biotechnologies Inc. (5.62B), less than Anixa Biosciences, Inc. (100.61M), less than INmune Bio, Inc. (157.41M), greater than PolyPid Ltd. (13.21M), less than Zura Bio Limited (132.02M), less than Annexon, Inc. (481.81M), less than Icosavax, Inc. (713.87M), less than Wave Life Sciences Ltd. (582.01M), greater than Gain Therapeutics, Inc. (13.17M), greater than TFF Pharmaceuticals, Inc. (2.94M), less than aTyr Pharma, Inc. (138.44M), greater than Palisade Bio, Inc. (-7034634.00), greater than ContraFect Corporation (-1135867.00), greater than Allarity Therapeutics, Inc. (7.17M), greater than CNS Pharmaceuticals, Inc. (2.52M), greater than Windtree Therapeutics, Inc. (1.17M),

Build a custom stock screener for IN8bio, Inc. (INAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IN8bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IN8bio, Inc. (INAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IN8bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is IN8bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for IN8bio, Inc. (INAB)?

What is the 3-year average Enterprise Value for IN8bio, Inc. (INAB)?

What is the 5-year average Enterprise Value for IN8bio, Inc. (INAB)?

How does the current Enterprise Value for IN8bio, Inc. (INAB) compare to its historical average?